| 2024 Active Requests for Applications (RFA's) | |
| RFA No. and Title | Status - Expiration |
|---|---|
| CA24-017 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | ACTIVE - NOV 16, 2024 |
| CA24-013 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | ACTIVE - OCT 02, 2024 |
| CA24-006 Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional) | ACTIVE - DEC 05, 2024 |
| 2023 Active Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR23-051 Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) | ACTIVE - OCT 24, 2025 |
| 2022 Active Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR22-234 The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) | ACTIVE - JUN 21, 2025 |
| PAR22-162 Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) | ACTIVE - MAR 01, 2025 |
| PAR22-161 Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) | ACTIVE - MAR 01, 2025 |
| PAR22-147 Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) | ACTIVE - NOV 02, 2024 |
| PAR22-049 Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) | ACTIVE - SEP 14, 2024 |
| 2022 Active Trans-NIH Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR22-123 Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) | ACTIVE - JAN 08, 2025 |
| 2021 Active Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR21-334 Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) | ACTIVE - JUN 12, 2024 |
| PAR21-330 Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) | ACTIVE - OCT 12, 2024 |
| 2021 Active Trans-NIH Program Announcements (PAs) | |
| PA No. and Title | Status - Expiration |
|---|---|
| PAR21-343 Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) | EXPIRED - APR 19, 2024 |